Cipla launches Yurpeak (tirzepatide) for the treatment of obesity and type 2 diabetes in India
Tirzepatide is the first and only dual agonist glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
Tirzepatide is the first and only dual agonist glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
It's an acquisition that aims at forming one of the US's largest oncology trial networks
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
The company introduced the ExcelSign E12 and E17 modular patient monitors, the Relife 1000 biphasic defibrillator, and a new OT charting software
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
The 7,000th store was inaugurated in Ayodhya, Uttar Pradesh
Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor
The clearance for TELLTALE positions Transmural Systems at the forefront of next-generation electrosurgical solutions for structural heart interventions
Solventum aims to accelerate innovation in acute wound care, expand its market reach, and deliver enhanced solutions for patients, clinicians, and shareholders
Subscribe To Our Newsletter & Stay Updated